Revvity aims to accelerate breakthroughs in cancer research
Revvity is positioning its technologies as a connected engine for discovery
Revvity is positioning its technologies as a connected engine for discovery
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
Collaboration streamlines patient access to oncology clinical trials
The addition of Abexxa’s expertise complements Boehringer Ingelheim’s current approaches to the treatment of difficult-to-treat solid cancers and especially those resistant to available immunotherapies
Access to genomic testing, not therapy cost, is the biggest challenge
Highlighting KEYTRUDA & expanding cancer pipeline
IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues
Selvax, founded in 1987, is focused on developing novel immunotherapy solutions with applications in both human and veterinary oncology
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Subscribe To Our Newsletter & Stay Updated